Professor Emeritus of Pediatrics and Communicable Diseases
[email protected]
Available to mentor
Jess G Thoene
Professor Emeritus/a
-
Venkatarangan V, Zhang W, Yang X, Thoene J, Hahn SH, Li M. J Clin Invest, 2023 Oct 2; 133 (19):Journal ArticleER-associated degradation in cystinosis pathogenesis and the prospects of precision medicine.
DOI:10.1172/JCI169551 PMID: 37561577 -
Thoene J, Gavin RF, Towne A, Wattay L, Ferrari MG, Navarrete J, Pal R. Mol Genet Metab, 2022 137 (1-2): 192 - 200.Journal ArticleIn vitro activity of cysteamine against SARS-CoV-2 variants.
DOI:10.1016/j.ymgme.2022.08.009 PMID: 36115282 -
Barshop BA, Jonas AJ, Gahl WA, Thoene JG. Mol Genet Metab, 2022 Jun 2;Journal ArticleIn memoriam: Jerry Allan Schneider, 1937-2021.
DOI:10.1016/j.ymgme.2022.05.003 PMID: 35659502 -
Yang D, Van Phuc Nguyen , Song J, Kong X, Xu J, Zhang J, Del Monte MA, Paulus Y, Thoene J, Chen YE. Molecular Genetics and Metabolism, 2022 Apr; 135 (4): 306 - 308.Journal ArticleA RABBIT MODEL OF CYSTINOSIS HAS DEPOSITION OF CYSTINE CRYSTALS IN THE CORNEA
DOI:10.1016/j.ymgme.2022.01.099 -
Ames EG, Thoene JG. Cells, 2022 Feb 15; 11 (4):Journal ArticleProgrammed Cell Death in Cystinosis.
DOI:10.3390/cells11040670 PMID: 35203319 -
Thoene J, Gavin RF, Towne A, Wattay L, Ferrari MG, Pal R. bioRxiv,PreprintIn Vitro Activity of Cysteamine Against SARS-CoV-2 Variants
DOI:10.1101/2021.10.02.462862 -
Thoene JG, DelMonte MA, Mullet J. Mol Genet Metab Rep, 2020 Jun; 23: 100587Journal ArticleMicrovesicle delivery of a lysosomal transport protein to ex vivo rabbit cornea.
DOI:10.1016/j.ymgmr.2020.100587 PMID: 32280591 -
Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, Afenjar A, Chantot-Bastaraud S, Mignot C, Lardennois C, Nava C, Schwarz N, Gérard M, Perrin L, Doummar D, Auvin S, Miranda MJ, Hempel M, Brilstra E, Knoers N, Verbeek N, van Kempen M, Braun KP, Mancini G, Biskup S, Hörtnagel K, Döcker M, Bast T, Loddenkemper T, Wong-Kisiel L, Baumeister FM, Fazeli W, Striano P, Dilena R, Fontana E, Zara F, Kurlemann G, Klepper J, Thoene JG, Arndt DH, Deconinck N, Schmitt-Mechelke T, Maier O, Muhle H, Wical B, Finetti C, Brückner R, Pietz J, Golla G, Jillella D, Linnet KM, Charles P, Moog U, Õiglane-Shlik E, Mantovani JF, Park K, Deprez M, Lederer D, Mary S, Scalais E, Selim L, Van Coster R, Lagae L, Nikanorova M, Hjalgrim H, Korenke GC, Trivisano M, Specchio N, Ceulemans B, Dorn T, Helbig KL, Hardies K, Stamberger H, de Jonghe P, Weckhuysen S, Lemke JR, Krägeloh-Mann I, Helbig I, Kluger G, Lerche H, Møller RS. Brain, 2017 May 1; 140 (5): 1316 - 1336.Journal ArticleGenetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
DOI:10.1093/brain/awx054 PMID: 28379373